Barst RJ - Search Results

1

Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension.

Oudiz RJ, Widlitz A, Beckmann XJ, Camanga D, Alfie J, Brundage BH, Barst RJ. Oudiz RJ, et al. Among authors: barst rj. Chest. 2004 Jul;126(1):90-4. doi: 10.1378/chest.126.1.90. Chest. 2004. PMID: 15249447

2

Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.

Oudiz RJ, Schilz RJ, Barst RJ, Galié N, Rich S, Rubin LJ, Simonneau G; Treprostinil Study Group. Oudiz RJ, et al. Among authors: barst rj. Chest. 2004 Aug;126(2):420-7. doi: 10.1378/chest.126.2.420. Chest. 2004. PMID: 15302727 Clinical Trial.

3

Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial.

Tapson VF, Gomberg-Maitland M, McLaughlin VV, Benza RL, Widlitz AC, Krichman A, Barst RJ. Tapson VF, et al. Among authors: barst rj. Chest. 2006 Mar;129(3):683-8. doi: 10.1378/chest.129.3.683. Chest. 2006. PMID: 16537868 Clinical Trial.

4

Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study.

Barst RJ, Rich S, Widlitz A, Horn EM, McLaughlin V, McFarlin J. Barst RJ, et al. Chest. 2002 Jun;121(6):1860-8. doi: 10.1378/chest.121.6.1860. Chest. 2002. PMID: 12065350 Clinical Trial.

5

Pulmonary arterial hypertension in children.

Rosenzweig EB, Widlitz AC, Barst RJ. Rosenzweig EB, et al. Among authors: barst rj. Pediatr Pulmonol. 2004 Jul;38(1):2-22. doi: 10.1002/ppul.20051. Pediatr Pulmonol. 2004. PMID: 15170869 Review.

6

Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension.

Horn EM, Widlitz AC, Barst RJ. Horn EM, et al. Among authors: barst rj. Expert Opin Investig Drugs. 2004 Nov;13(11):1483-92. doi: 10.1517/13543784.13.11.1483. Expert Opin Investig Drugs. 2004. PMID: 15500395

7

Effects of long-term bosentan in children with pulmonary arterial hypertension.

Rosenzweig EB, Ivy DD, Widlitz A, Doran A, Claussen LR, Yung D, Abman SH, Morganti A, Nguyen N, Barst RJ. Rosenzweig EB, et al. Among authors: barst rj. J Am Coll Cardiol. 2005 Aug 16;46(4):697-704. doi: 10.1016/j.jacc.2005.01.066. J Am Coll Cardiol. 2005. PMID: 16098438 Free article.

8

von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension.

Kawut SM, Horn EM, Berekashvili KK, Widlitz AC, Rosenzweig EB, Barst RJ. Kawut SM, et al. Among authors: barst rj. Chest. 2005 Oct;128(4):2355-62. doi: 10.1378/chest.128.4.2355. Chest. 2005. PMID: 16236894

9

Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension.

Oudiz RJ, Barst RJ, Hansen JE, Sun XG, Garofano R, Wu X, Wasserman K. Oudiz RJ, et al. Among authors: barst rj. Am J Cardiol. 2006 Jan 1;97(1):123-6. doi: 10.1016/j.amjcard.2005.07.129. Epub 2005 Nov 10. Am J Cardiol. 2006. PMID: 16377296 Clinical Trial.

10

Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentan.

Benza RL, Mehta S, Keogh A, Lawrence EC, Oudiz RJ, Barst RJ. Benza RL, et al. Among authors: barst rj. J Heart Lung Transplant. 2007 Jan;26(1):63-9. doi: 10.1016/j.healun.2006.10.019. J Heart Lung Transplant. 2007. PMID: 17234519 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters